Ironwood Pharmaceuticals
IRWD • NASDAQ
Ironwood Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Thomas A. McCourt, with a market cap of $723.9M.
CEOThomas A. McCourt
Market Cap$723.9M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees267.0
Websiteironwoodpharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Ironwood Pharmaceuticals
Date
Wednesday, May 6, 2026 (in 3 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.11
Revenue Estimate
$76.8M
Earnings History
Past 11 earnings reports for Ironwood Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | $0.24Est: $0.11 | +118.2% | $122.1MEst: $72.8M | +67.6% |  10-Q |
| Aug 7, 2025 | Q2 2025 | $0.14Est: $0.02 | +600.0% | $85.2MEst: $61.9M | +37.6% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.14Est: -$0.01 | -1300.0% | $41.1MEst: $66.8M | -38.4% | 10-Q |
| Feb 27, 2025 | Q4 2024 | $0.02Est: $0.08 | -75.0% | $90.5MEst: $93.9M | -3.5% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.02Est: $0.08 | -75.0% | $91.6MEst: $91.3M | +0.4% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.01Est: $0.15 | -93.3% | $94.4MEst: $107.0M | -11.8% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.02Est: $0.20 | -110.0% | $74.9MEst: $106.3M | -29.6% | 10-Q |
| Feb 15, 2024 | Q4 2023 | $0.00Est: $0.21 | -100.0% | $117.6MEst: $117.5M | +0.1% | 10-K |
| Nov 9, 2023 | Q3 2023 | $0.12Est: $0.16 | -25.0% | $113.7MEst: $112.9M | +0.8% | — |
| Aug 8, 2023 | Q2 2023 | $0.31Est: $0.25 | +24.0% | $107.4MEst: $103.7M | +3.5% | 10-Q |
| May 4, 2023 | Q1 2023 | $0.25Est: $0.24 | +4.2% | $104.1MEst: $100.4M | +3.6% | 10-Q |